Response of Fibroblastic Rheumatism to Infliximab
Joint Authors
Menta Simonsen Nico, Marcello
Romiti, Ricardo
Levy Neto, Mauricio
Source
Dermatology Research and Practice
Issue
Vol. 2009, Issue 2009 (31 Dec. 2009), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2010-02-01
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
Onset is usually sudden with symmetrical articular involvement of both small and large joints, occurrence of solid skin nodules, and rapid progression.
Treatment is generally unrewarding.
Here we report a severe and disabling case of FR responding favorably to infliximab therapy.
After 32 weeks of continuous treatment, skin lesions dramatically improved and arthropathy partially regressed.
American Psychological Association (APA)
Romiti, Ricardo& Levy Neto, Mauricio& Menta Simonsen Nico, Marcello. 2010. Response of Fibroblastic Rheumatism to Infliximab. Dermatology Research and Practice،Vol. 2009, no. 2009, pp.1-2.
https://search.emarefa.net/detail/BIM-492827
Modern Language Association (MLA)
Romiti, Ricardo…[et al.]. Response of Fibroblastic Rheumatism to Infliximab. Dermatology Research and Practice No. 2009 (2009), pp.1-2.
https://search.emarefa.net/detail/BIM-492827
American Medical Association (AMA)
Romiti, Ricardo& Levy Neto, Mauricio& Menta Simonsen Nico, Marcello. Response of Fibroblastic Rheumatism to Infliximab. Dermatology Research and Practice. 2010. Vol. 2009, no. 2009, pp.1-2.
https://search.emarefa.net/detail/BIM-492827
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-492827
